Jenny Lee, managing partner at GGV Capital, discusses the venture capital environment in China
Topics covered include: GGV targeting early- to growth-stage deals in its latest fund; cross-border transactions; how US start-ups can be successful in China; and future trends in tech sector investment.
China healthcare-focused GP C-Bridge Capital and Tasly Holding, a traditional Chinese medicine business, have agreed to invest $150 million in a newly-created entity formed through the merger of two local pharmaceutical companies.
Kuaishou, a Chinese live-streaming video app backed by VC investors and search engine Baidu, has raised $350 million in a new round of funding led by Tencent Holdings.
The Riverside Company has completed its second deal in Malaysia as Drex-Chem Malaysia (now known as DCM Asia), the chemicals distributor it bought in 2014, acquired Erapoly Marketing.
The Carlyle Group has led an investment of more than $100 million in Indian delivery e-commerce logistics service Delhivery. Existing backer Tiger Global Management also took part in the funding round.